What is Pristiq (Desvenlafaxine)
Pristiq is the brand name for the molecule “desvenlafaxine,” one of the new generation antidepressants. It was introduced in late 2008 by Wyeth (now part of Pfizer Inc.). Wyeth also developed and marketed Effexor, which is the brand name for the molecule “venlafaxine.” Pristiq and Effexor are closely related molecules affecting brain levels of serotonin and norepinephrine, neurotransmitters believed to be linked to mood. Those neurotransmitters are cyclically released and absorbed between nerve cells in the brain each time a nerve cell conveys a signal. Theoretically, lower neurotransmitter levels between nerve cells leads to lowered mood.
Drugs like Pristiq and Effexor are believed to create the effect of increasing between-cell serotonin and norepinephrine levels by reducing their re-absorption between firings of nerve cells. Pristiq and Effexor operate by blocking proteins that enable nerve cells’ re-absorption of these neurotransmitters, i.e. they block “reuptake” proteins, thereby leaving more active neurotransmitters in the gaps between nerves (synapses). Since the neurotransmitters affected are serotonin and norepinephrine, Pristiq and Effexor are classified as serotonin-norepinephrine reuptake inhibitors (SNRIs).
Pristiq and Effexor operate with essentially the same active ingredient. Shortly after a patient takes venlafaxine (Effexor), it is broken down (“metabolized”) into mostly desvenlafaxine, the molecule sold as Pristiq. Desvenlafaxine is a synthetic form of Effexor’s isolated major active metabolite. When most people with normal metabolisms take venlafaxine (Effexor) – 70% of the benefit comes from its being metabolized into desvenlafaxine (Pristiq), so the effects of both Effexor and Pristiq are very similar. This means that when taking Pristiq, a patient is simply skipping breaking down the combined molecules comprising Effexor and undergoing essentially a treatment of Effexor’s active ingredient.
Effexor, which was introduced in 1993, will be losing its patent in 2013. By introducing Pristiq, Wyeth/Pfizer has been able to, in a way, extend the patent of their blockbuster antidepressant.
Since Effexor and Pristiq rely upon the same active ingredient, with essentially the same effect, they also share similar side effects and risks. One of these shared side effects is the risk of birth defects associated with taking antidepressants in the early stages of pregnancy.
Pristiq, in particular, has been the subject of a few animal studies which found that the medication does have an impact on animal birth defects. The side effects in humans, however, is still relatively unknown. Because of this, the FDA has classified Pristiq as a “Category C” drug, which means that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risk. The Pregnancy Categories measure the teratogenic effects a drug has on a fetus (teratogenic or embryocidal or other). Teratogenic means that a drug or other substance is capable of interfering with the development of a fetus. Embryocidal pertains to the killing of an embryo.
Health providers are still allowed to prescribe Pristiq to pregnant women, only if they believe the benefits of the drug outweigh the risks. With the risks still relatively unknown however, it is difficult to gauge whether any benefit is greater than any potential risk to an unborn child.
On July 19, 2006, the FDA issued a Public Health Advisory for SSRIs, including Celexa (citalopram), Fluvoxamine, Lexapro (escitalopram), Symbyax (olanzapine and fluoxetine) and Zoloft (sertraline) based on a study that suggests there may be additional risks of SSRI medications during pregnancy. In this study, PPHN (Persistent pulmonary hypertension of the newborn) was six times more common in babies whose mothers took an SSRI antidepressant after the 20th week of the pregnancy compared to babies whose mothers did not take an antidepressant.

-
A ranking in The U.S. News – Best Lawyers® “Best Law Firms” is widely regarded by both client and legal professionals as a significant honor. It is considered the most reliable, unbiased source of legal referrals anywhere.
-
Baum Hedlund is proud to be a sponsor of The Truck Safety Coalition, a a group of caring individuals dedicated to reducing the number of deaths and injuries caused by truck-related crashes. Our support enables them to help families and save lives.
-
Law360 recognizes law firms that have a strong regional presence, working on important matters within their home state. “[Baum Hedlund] possesses a David v. Goliath-sized slingshot while seeking justice for everyday citizens it believes were harmed or killed through corporate wrongdoing.”
-
NLJ and American Lawyer Media honor law firms and attorneys as Elite Trial Lawyers for their cutting-edge legal work on behalf of plaintiffs in practice areas ranging from mass torts to securities litigation.
-
Best Lawyers is the oldest and most respected peer-review publication in the legal profession. A listing in Best Lawyers is widely regarded by both clients and legal professionals as a significant honor, conferred on a lawyer by his or her peers.
-
Less than one-half of one percent of firms across the nation have achieved this ranking. A firm must have a high percentage of lawyers who have achieved the prestigious AV® Preeminent rating by Martindale-Hubbell®.
-
The National Law Journal inducted Baum Hedlund into the Verdicts Hall of Fame for obtaining the $2 billion landmark verdict in the Roundup cancer case of Pilliod et al. v. Monsanto. The verdict was #1 in California and #2 in the U.S. in 2019 and is #9 in American history.
-
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement.
-
The National Trial Lawyers Top 100 recognized the law firms of Baum Hedlund Aristei & Goldman, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the groundbreaking case of Dewayne “Lee” Johnson v. Monsanto Company.
-
An AV® rating reflects an attorney who has reached the heights of professional excellence. The rating signifies the highest legal ability, and very high adherence to professional standards of conduct, ethics, reliability, and diligence.
-
Baum Hedlund is proud to have all of its lawyers listed in Avvo, a legal directory connecting people in need of legal services with lawyers and connecting lawyers to lawyers. Eight of our attorneys have earned a 10.0 perfect rating with Avvo.
-
The National Board of Trial Advocacy is one of the nation’s largest and oldest private board-certification organizations for attorneys. Two of our shareholders are certified in multiple specialties.
-
CA and USATopVerdict.com ranks our $2 billion verdict in Pilliod et al. v. Monsanto as the biggest verdict in California and the second largest verdict in the U.S. in 2019. It is the ninth largest verdict in U.S. history.
-
Published annually, the Lawdragon 500 Leading Plaintiff Consumer Lawyers list recognizes the “best of the best” in this area of the law through nominations, research, and review by a board of their peers.
-
Multi-Million Dollar Advocates Forum is one of the most prestigious groups of trial lawyers in the United States. Membership is limited to attorneys who have won million and multi-million-dollar verdicts and settlements.
-
In 2020, Law360 honored the law firms ”behind the litigation wins and major deals that resonated throughout the legal industry.” It recognized our success in several landmark cases.
-
In 2018, our $289 million Johnson v. Monsanto verdict was the largest personal injury verdict in California. TopVerdict.com also ranked it #2 among all verdicts in California and #10 in the nation.
-
The Bar Register is the definitive guide to the most distinguished law firms in America. It includes only those select law practices that have earned the highest rating in the Martindale-Hubbell Law Directory and have been designated by their colleagues as preeminent in their field.
-

Firm Reviews
What Our Clients Are Saying
-
I Can’t Imagine a Better Law Firm
“Multiple lawyers recommended Baum Hedlund to me and I have been consistently impressed with the quality of their work.”
- Best Law Firms Survey -
They Are About Changing the Systems...
“Baum Hedlund are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.”
- Kim Witczak -
Top Legal Minds in the Country
“The Baum, Hedlund firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”
- From Best Lawyers® Best Law Firms -
Diligent & Professional Representation
“Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”
- W.T. -
Our Best Interest Was Always Number One on Your List
“A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”
- G.C. & C.C